Literature DB >> 16107887

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.

S Gesk, R D Gascoyne, B Schnitzer, N Bakshi, D Janssen, W Klapper, J I Martín-Subero, R Parwaresch, R Siebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16107887     DOI： 10.1038/sj.leu.2403921

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.

Authors:  Elaine S Jaffe; Stefania Pittaluga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  An unusual case of anaplastic lymphoma kinase-positive large B-cell lymphoma in an elderly patient: A case report and discussion.

Authors:  Hanzhen Xiong; Shao-Yan Liu; Yue-Xin Yang; Xue-Xian Tan; Qiu-Ping Luo; Juan Peng; Zhong-Tang Xiong; Hui Chen; Juan Chen; Zhi Li; Qing-Ping Jiang
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

3.  Clathrin heavy chain gene fusions expressed in human cancers: analysis of cellular functions.

Authors:  Maria K E Blixt; Stephen J Royle
Journal:  Traffic       Date:  2011-03-24       Impact factor: 6.215

Review 4.  The histological classification of diffuse large B-cell lymphomas.

Authors:  Yi Xie; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

Review 5.  The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors:  Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

6.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity.

Authors:  Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2009-03-13

7.  Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.

Authors:  Leandro Cerchietti; Christine Damm-Welk; Inga Vater; Wolfram Klapper; Lana Harder; Christiane Pott; Shao Ning Yang; Alfred Reiter; Reiner Siebert; Ari Melnick; Willi Woessmann
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

8.  Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.

Authors:  Jiandong Wang; Qin Shen; Qunli Shi; Bo Yu; Xuan Wang; Kai Cheng; Guangming Lu; Xiaojun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2014-12-21

9.  Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report.

Authors:  Meng Zhang; Ling Jin; Yan-Long Duan; Jing Yang; Shuang Huang; Mei Jin; Guang-Hua Zhu; Chao Gao; Yi Liu; Nan Zhang; Chun-Ju Zhou; Zi-Fen Gao; Qin-Long Zheng; Dong Chen; Yong-Hong Zhang
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 10.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Brady Beltran; Jorge Castillo; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Luis Riva; Eric Winer
Journal:  J Hematol Oncol       Date:  2009-02-27       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.